Skip to content

Paradigm Clash · Episode 7 · 4 min · English audio · 6 June 2026

Science Showdown: Where Brilliant Minds Clash on Unsettled Ideas

Weekly debates pit top thinkers against each other on science's most hotly contested questions.

From the show

Paradigm Clash

Dive into "Clash of Minds" where two intellectual titans confront the elusive mysteries of consciousness.

Podcast · 26 episodes · Latest 24 October 2026 · English audio

Make a show like thisWith the Lissin app for iPhone

What this episode covers

Weekly debates pit top thinkers against each other on science's most hotly contested questions.

Play this episode

4 min of audio, free in your browser — no account, no app.

Transcript

690 words · Script-based transcript; wording may differ from the recording.

In 1954, two scientists, Armitage and Doll, showed that your risk of getting most cancers increases with roughly the fifth power of your age. It's one of the oldest, most solid facts in cancer research. We talked last week about how epigenetics can rewrite your story over a lifetime, but this is different. This isn't just about what you inherit; it’s about what breaks down over time. And the central debate is what, exactly, is breaking. Exactly. The dominant theory for seventy years has been the Somatic Mutation Theory, or SMT. It's simple, elegant, and intuitive. Your cells divide, they make mistakes copying DNA, and those mutations pile up. Get enough of the wrong mutations in the wrong genes, and one cell goes rogue.

That's cancer. And we have the receipts. We can sequence tumors and find the mutations. We can track specific mutational signatures, like SBS1 and SBS5, that accumulate like clockwork as we age. It’s a direct link between aging, DNA damage, and cancer. It’s the foundation of modern oncology. I hear you, but it’s an incomplete story. It treats the cell like a lone actor. The alternative is the Tissue Organization Field Theory, or TOFT. It argues that cancer isn't a disease of a single rogue cell, but a disease of a broken tissue. The context, the microenvironment, the cellular neighborhood—that’s what breaks first. Okay, but that sounds... abstract. I can point to a specific gene mutation. How do you point to a "broken neighborhood"?

You look at how healthy tissues work. A 2026 study in Nature Physics showed that simple physical adhesion—how sticky cells are to each other—can literally flip a switch and cause disorganized embryonic cells to form structured tissue. It’s the collective, not the individual cell, that creates order. TOFT says cancer is that process in reverse—a loss of collective order. So you’re saying a potentially cancerous cell, with all the right mutations, could be kept in line by its neighbors? Yes! And we have evidence for this. If you take certain cancer cells and implant them into a healthy, developing embryo, they often behave normally. They integrate into the tissue. The "bad" cell becomes "good" because the neighborhood is healthy.

The Somatic Mutation Theory has no good explanation for that. Alright, I'll give you that one. The phenomenon of cancer reversibility is a tough one for a pure gene-centric view. But the mutation theory gives us concrete targets. We can design drugs to block the proteins made by mutated genes. How do you drug a "disrupted microenvironment"? You're thinking like a mechanic, looking for a broken part. I'm thinking like an ecologist, looking at a failing ecosystem. And we are learning how to treat the ecosystem. Look at immunotherapy. It doesn't target the cancer cell directly. It re-educates the immune system—a key part of the tissue environment—to do its job. New AI models are now mapping the tumor's entire spatial layout, showing how the location of immune structures predicts survival.

That's fair. The work on the tumor microenvironment is undeniable. But it feels like you're sidelining the primary cause. We know that by 2050, we're projected to see over thirty-five million new cancer cases a year. The vast majority will be driven by that clock-like accumulation of mutations that comes with age. I'm not sidelining it. I'm re-contextualizing it. The mutations are the gasoline, but the broken tissue organization is the spark. Why do some people have tissues riddled with mutations but never get cancer? Because the tissue architecture holds. The neighborhood watch is still on patrol. It’s when the watch gets defunded that the trouble starts. So the mutations are necessary, but not sufficient.

Precisely. The gene-centric view has given us amazing tools, but it's hit a wall in explaining complexity, recurrence, and why some cancers just... stop. We've been looking for the broken cog in the machine for decades. Maybe the real problem is that the machine itself is falling apart. It leaves you wondering what we're really fighting then. Is cancer a disease of broken genes, or a disease of broken cellular societies? And which one is harder to fix?

Sources for this episode

Made with AI. AI may assist this episode’s research, and it writes and voices the episode. Neither the transcript nor this page is an editorial fact check. To report an error, email hi@lissin.com with the episode URL and timestamp. See our editorial standards.

Make your own show like this

Choose a topic you want to hear about, and Lissin makes the show around that choice.

Get Lissin for iPhone

More to listen to

Collections with this show: Science podcasts

About Paradigm Clash

In this AI-generated podcast, two voices debate contested questions about consciousness, quantum physics and cosmology.

All 26 episodes · More podcast shows